Made Scientific Expands Board for Cell Therapy Scale-Up
PRINCETON, New Jersey, April 30, 2026 Made Scientific, a U.S.-based cell therapy contract development and manufacturing organization (CDMO), announced...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine solid tumors targeted therapy
PRINCETON, New Jersey, April 30, 2026 Made Scientific, a U.S.-based cell therapy contract development and manufacturing organization (CDMO), announced...
DURHAM, N.C. | December 23, 2025 — Pelthos Therapeutics announced the expansion of its Board of Directors with the...
Dateline: November 14, 2025 — Bagsværd, DenmarkNovo Nordisk A/S announced a series of major Board of Directors changes following...
